Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07447076) titled 'Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Sabine Mueller, MD, PhD
Condition:
Recurrent Atypical Teratoid/Rhabdoid Tumor
Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS
Intervention:
Procedure: Lumber Puncture
Procedure: Blood Specimen Collection
Procedure: Magnetic resonance imaging (MRI)
Drug: Gemcitabine
Drug: Paxalisib
Recruitment Status: Not re...